ATRC vs VLTO · rev $294.9M vs P/E 29, rev $5.50B
AtriCure Inc (ATRC) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
Latest reported ATRC revenue for 2026-06-30 was $294.9M. Net income was $9.1M. ATRC currently screens at market cap $1.37B.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
ATRC currently screens at market cap $1.37B. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the ATRC and VLTO stock pages for the full models.
Not investment advice.